Results 111 to 120 of about 2,179,599 (299)

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

Intoxicação por Amorimia spp. em ruminantes Poisoning by Amorimia spp. in ruminants

open access: yesCiência Rural, 2013
No Brasil, um dos grupos mais importantes de plantas tóxicas é o das que causam morte súbita associada ao exercício. Integram esse grupo, plantas das famílias Rubiaceae, Bignoniaceae e Malpighiaceae.
Amélia Lizziane Duarte   +2 more
doaj  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Dutch survey pyrrolizidine alkaloids in animal forage [PDF]

open access: yes, 2009
Pyrrolizidine alkaloids (PAs) are secondary plant metabolites produced by a number of plants from the Asteraceae (Compositae), Boriginaceae and Fabaceae (Leguminosae) families.
Jong, J., de   +4 more
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Plantas tóxicas para ruminantes e equídeos do estado de Sergipe

open access: yesPesquisa Veterinária Brasileira
RESUMO: Em um levantamento feito nos anos de 2015 e 2016 no estado de Sergipe, com o objetivo de conhecer as plantas tóxicas para ruminantes e equídeos, foram visitadas propriedades rurais em 16 municípios, englobando as mesorregiões do litoral, agreste ...
Eduardo M. Nascimento   +2 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Chronic Edema Associated with Cor Pulmonale in Cattle

open access: yesAnimals
For nearly 30 years, a chronic disease causing severe chronic subcutaneous edema of unknown etiology has been affecting cattle in the Central–Northern and Central–Southern mesoregions of the State of Bahia, Brazil.
Laís G. Caymmi   +8 more
doaj   +1 more source

Acknowledgement to Reviewers of Plants in 2014

open access: yes, 2015
The editors of Plants would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...
Plants Editorial Office, Office, Plants
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy